Home › Lobular Carcinoma
Lobular Carcinoma clinical trials recruiting in the U.S.
10 studies for Lobular Carcinoma are recruiting participants at sites across the United States.
By state
Recently updated studies
[68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC)
RecruitingPhase 1
Ages 18 to 89 · All sexes · Updated Sep 14, 2026 · NCT07020806Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT05964504A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Recruiting
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT05837767Biomarkers to Detect Endocrine Therapy Resistance
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT06067503Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
RecruitingPhase 1/2
Ages 16 and older · All sexes · Updated Aug 20, 2026 · NCT05269381Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT05919108InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Aug 17, 2026 · NCT05463796[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RecruitingPhase 1/2
Ages 18 to 80 · All sexes · Updated Jun 23, 2026 · NCT07432633A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer
RecruitingPhase 2
Ages 50 and older · Women · Updated Jun 4, 2026 · NCT07483307Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastatic Lobular Breast Cancer
RecruitingObservational study
Ages 18 and older · Women · Updated Jan 20, 2026 · NCT06666439From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.